Business Context and Reporting Period
Company: Semtech Corporation
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended January 27, 2002
Industry: Analog and mixed-signal semiconductors
Primary Markets: Computer (40%), Communications (32%), and Industrial (25%).
Semtech designs, produces, and markets analog and mixed-signal semiconductors for applications including computers, cellular phones, and automated test equipment. The company operates as a fabless manufacturer for most of its product lines, outsourcing wafer fabrication to third-party foundries, though it maintained one internal facility in Corpus Christi, Texas, which it announced plans to close in 2002.
Key Financial Metrics
| Metric | Fiscal 2002 | Fiscal 2001 | Change |
|---|---|---|---|
| Net Sales | $191.2 million | $256.7 million | (26%) |
| Gross Profit | $93.3 million | $144.9 million | (36%) |
| Gross Margin | 49% | 56% | -700 bps |
| Operating Income | $27.0 million | $76.7 million | (65%) |
| Net Income | $26.0 million | $60.2 million | (57%) |
| Diluted EPS | $0.33 | $0.79 | (58%) |
| Cash from Operations | $64.7 million | $86.0 million | (25%) |
| Working Capital | $403.0 million | $530.7 million | (24%) |
| Long-Term Debt | $364.3 million | $400.0 million | (9%) |
Note: Net Income includes an extraordinary gain of $1.6 million (net of tax) from the extinguishment of debt.
Material Changes vs. Prior Period
- Revenue Decline: Net sales dropped 26% due to a severe downturn in the semiconductor industry, specifically in the industrial (ATE) and wireline communications markets. The Standard Semiconductor Products segment, representing 92% of sales, declined 24%.
- Margin Compression: Gross margin fell from 56% to 49%. This was driven by lower sales volumes and a one-time inventory write-down of $14.0 million in the second quarter due to excess and obsolete inventory.
- Cost Reductions: Operating expenses decreased slightly in absolute dollars ($68.2M to $66.3M) due to headcount reductions (approx. 200 employees) and variable expense cuts, but increased as a percentage of sales (27% to 35%) due to the revenue decline.
- Debt Repurchase: The company repurchased $35.7 million face value of convertible subordinated notes at a discount, recognizing a $2.3 million pre-tax extraordinary gain.
Outlook, Risks, and Management Commentary
- Manufacturing Strategy: Management confirmed a strategic shift to 100% outsourced wafer fabrication by the end of calendar 2002, including the closure of the Corpus Christi, Texas facility. This aims to reduce fixed costs and increase operating flexibility.
- Market Outlook: Management cited weak industry conditions and economic slowdowns in the U.S. as primary headwinds. The company expects continued volatility in the computer and communications infrastructure markets.
- Key Risks:
- Customer Concentration: Agilent Technologies (and subcontractors) accounted for 13% of sales in 2002; one Asian distributor accounted for 12%.
- Supply Chain: Reliance on foreign subcontractors, with 28% of silicon sourced from a single foundry in China.
- Environmental Liabilities: A pending Superfund settlement of $765,000 was recorded. Potential liability exists for the Davis Chemical Company site, though no reserve has been established.
- Intellectual Property: Heavy reliance on design talent and patents, with risks of infringement litigation.
Investor Verification Checklist
- Inventory Valuation: Verify the adequacy of remaining inventory reserves given the $14M write-down and ongoing industry downturn.
- Customer Concentration: Monitor sales trends with Agilent Technologies and the primary Asian distributor, as their performance significantly impacts revenue.
- Debt Obligations: Review the terms of the remaining $364.3 million in convertible subordinated notes (due 2007, convertible at $42.23/share) and interest expense impact.
- Manufacturing Transition: Assess the execution risk and cost implications of closing the Corpus Christi fab and transitioning 100% to outsourced foundries.
- Environmental Contingencies: Track the status of the Davis Chemical Company site investigation for potential future liabilities.